Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - May 2007

  1. Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2006-2007.   Pediatrics. 2007 Apr; 119(4):846-851.

  2. I Know a Flu Shot Is Recommended for People Over 50, but Should I Get Any Other Vaccines?   Johns Hopkins Med Lett Health After 50. 2007 Apr; 19(2):8.

  3. European Immunization Week: 16-22 April.   Euro Surveill; 2007 Apr 12;12(4):E070412.3.

  4. Agampodi, S. B.; Amarasinghe, D.  Private Sector Contribution to Childhood Immunization: Sri Lankan Experience.   Indian J Med. 2007 Apr; 61(4):192-200.

  5. Ahonkai, A.; Lechtzin, N.  A Case for Vaccination.   Am J Med. 2007 Apr; 120(4):319-21.

  6. Almanzar, G.; Herndler-Brandstetter, D.; Chaparro, S. V.; Jenewein, B.; Keller, M.; Grubeck-Loebenstein, B.  Immunodominant Peptides From Conserved Influenza Proteins - A Tool for More Efficient Vaccination in the Elderly?   Wien Med Wochenschr. 2007 Mar; 157 (5-6): 116-121..

  7. Altuzarra, H. R.; Valenzuela, B. MT; Trucco, A. O.; Inostroza, S. J.; Granata, S. P.; Fleiderman, V. J.  [Nasal Carriage of Streptococcus Pneumoniae in Elderly Subjects According to Vaccination Status.].   Rev Med Chil. 2007 Feb; 135 (2): 160-166; Epub 2007 Mar 28.

  8. Anand, S.; Barnighausen, T.  Health Workers and Vaccination Coverage in Developing Countries: an Econometric Analysis.   Lancet; 2007 Apr 14; 369 (9569): 1277-85

  9. Baccam, P.; Boechler, M.  Public Health Response to an Anthrax Attack: an Evaluation of Vaccination Policy Options.   Biosecur Bioterror. 2007 Mar; 5 (1): 26-34.

  10. Baicus, A.; Combiescu, M.; Persu, A.; ubert-Combiescu, A.  Immune Status to Polioviruses in the Children Population of Romania Between 2002-2005 As Indicated by Serological Investigation in Cases of Acute Flaccid Paralysis (AFP) and Facial Paralysis (FP) and Its Use As a "National Reference Value" to Evaluate the Vaccination Coverage in Particular Groups of Healthy Children.   Rev Med Chir Soc Med Nat Iasi. 2006 Oct-Dec;110 (4): 1004-11.

  11. Beermann, B.  [Some Corrections Concerning Vaccines Campaigns].   Lakartidningen. 2007 Mar 14-20;104 (11):885.

  12. Beigel, J.; Kohl, K. S.; Khuri-Bulos, N.; Bravo, L.; Nell, P.; Marcy, S. M.; Warschaw, K.; Ong-Lim, A.; Poerschke, G.; Weston, W.; Lindstrom, J. A.; Stoltman, G.; Maurer, T.  Rash Including Mucosal Involvement: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data.   Vaccine. 2007 March 13; [Epub ahead of print].

  13. Bettinger, J. A.; Scheifele, D. W.; Halperin, S. A.; Kellner, J. D.; Tyrrell, G.  Invasive Pneumococcal Infections in Canadian Children, 1998-2003: Implications for New Vaccination Programs.   Can J Public Health; 2007 Mar-Apr; 98 (2): 111-115.

  14. Boyce, T. G.  Vaccination Usage Among an Old-Order Amish Community in Illinois.   Pediatr Infect Dis J. 2007 Apr; 26 (4): 370.

  15. Bremner, S. A.; Carey, I. M.; DeWilde, S.; Richards, N.; Maier, W. C.; Hilton, S. R.; Strachan, D. P.; Cook, D. G.  Vaccinations, Infections and Antibacterials in the First Grass Pollen Season of Life and Risk of Later Hayfever.   Clin Exp Allergy. 2007 Apr; 37 (4): 512-7.

  16. Cesarone, M. R.; Belcaro, G.; Di, Renzo A.; Dugall, M.; Cacchio, M.; Ruffini, I.; Pellegrini, L.; Del, Boccio G.; Fano, F.; Ledda, A.; Bottari, A.; Ricci, A.; Stuard, S.; Vinciguerra, G.  Prevention of Influenza Episodes With Colostrum Compared With Vaccination in Healthy and High-Risk Cardiovascular Subjects: the Epidemiologic Study in San Valentino.   Clin Appl Thromb Hemost. 2007 Apr;13 (2): 130-6.

  17. Chyu, K. Y.; Nilsson, J.; Shah, P. K.  Active and Passive Immunization for Atherosclerosis.   Curr Opin Mol Ther; 9 (2): 176-182; April, 2007.

  18. Codec, O. CT; Luz, P. M.; Coelho, F.; Galvani, A. P.; Struchiner, C.  Vaccinating in Disease-Free Regions: a Vaccine Model With Application to Yellow Fever.   J R Soc Interface. 2007 Apr 18; [Epub ahead of print]

  19. Danova, J.; Gopfertova, D.; Prikazsky, V.; Bobak, M.  [Failures to Comply With the Routine Childhood Immunization Schedule Due to Contraindications and the Use of Alternative Vaccines in Children Aged 0-4 Years in the Czech Republic].   Epidemiol Mikrobiol Imunol. 2007 Feb; 56 (1): 33-7.

  20. Datta, M.  Vaccinating Infants With a Wide Long Needle Was Non-Inferior to a Narrow Short Needle for Immune Response. Evid Based Med. 2007 April;12 (2): 41.

  21. Davenport, M. P.; Price, D. A.; McMichael, A. J.  The T Cell Repertoire in Infection and Vaccination: Implications for Control of Persistent Viruses.   Curr Opin Immunol. 2007 Jun; 19 (3): 294-300. Epub 2007 Apr 12.

  22. De Soto, J.  Should HPV Vaccination Be Mandatory?   J Fam Pract. 2007 Apr; 56 (4): 267-8.

  23. Denis, F.; Alain, S.; Ploy, M. C.  [New Routes of Administration: Epidermal, Transcutaneous Mucosal Ways of Vaccination].   Med Sci (Paris). 2007 Apr; 23 (4): 379-85.

  24. Dilraj, A.; Sukhoo, R.; Cutts, F. T.; Bennett, J. V.  Aerosol and Subcutaneous Measles Vaccine: Measles Antibody Responses 6 Years After Re-Vaccination.  Vaccine. 2007 May 22; 25(21):4170-4.

  25. Duclos, P.; Okwo-Bele, J. M.  [Global Immunization Policies and Recommendations: Objectives and Process].   Med Sci (Paris). 2007 Apr; 23 (4): 409-16.

  26. Edelman, K.; He, Q.; Makinen, J.; Sahlberg, A.; Haanpera, M.; Schuerman, L.; Wolter, J.; Mertsola, J.  Immunity to Pertussis 5 Years After Booster Immunization During Adolescence.  Clin Infect Dis. 2007 May 15; 44(10):1271-7.

  27. Elkayam, O.; Ablin, J.; Caspi, D.  Safety and Efficacy of Vaccination Against Streptococcus Pneumonia in Patients With Rheumatic Diseases.   Autoimmun Rev. 2007 Apr; 6 (5): 312-4.

  28. Enger, K. S.; Stokley, S.  Meningococcal Conjugate Vaccine Uptake, Measured by Michigan's Immunization Registry.  J Adolesc Health. 2007 May; 40 (5):398-404. Epub 2007 Mar 9.

  29. Fry, L.; Baker, B. S.; Powles, A. V.  Psoriasis - A Possible Candidate for Vaccination.   Autoimmun Rev. 2007 Apr 6 (5):286-9. Epub 2006 Oct 2.

  30. Guiso, N.  [Impact of Vaccination on the Infectious Diseases Epidemiology: Example of Pertussis].  Med Sci (Paris). 2007 Apr; 23 (4): 399-403.

  31. Hanslik, T.; Boelle, P. Y.  [Benefit-Risk Assessment of Vaccination Strategies].   Med Sci (Paris). 2007 Apr; 23(4):391-8.

  32. Hofmann, J.  [Decreased Vaccination Reactions With Long Needles].   Med Monatsschr Pharm. 2007 Mar; 30 (3):112-3.

  33. Holvast, B.; Huckriede, A.; Kallenberg, C. G.; Bijl, M.  Influenza Vaccination in Systemic Lupus Erythematosus: Safe and Protective?   Autoimmun Rev. 2007 Apr; 6 (5): 300-5.

  34. Jit, M.; Edmunds, W. J.  Evaluating Rotavirus Vaccination in England and Wales Part II. The Potential Cost-Effectiveness of Vaccination.  Vaccine. 2007 16; 25 (20):3971-3979.

  35. Jones, J. F.; Kohl, K. S.; Ahmadipour, N.; Bleijenberg, G.; Buchwald, D.; Evengard, B.; Jason, L. A.; Klimas, N. G.; Lloyd, A.; McCleary, K.; Oleske, J. M.; White, P. D.  Fatigue: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data.  Vaccine.  2007 Mar 12; [Epub ahead of print].

  36. Jorch, G.; Tapiainen, T.; Bonhoeffer, J.; Fischer, T. K.; Heininger, U.; Hoet, B.; Kohl, K. S.; Lewis, E. M.; Meyer, C.; Nelson, T.; Sandbu, S.; Schlaud, M.; Schwartz, A.; Varricchio, F.; Wise, R. P.  Unexplained Sudden Death, Including Sudden Infant Death Syndrome (SIDS), in the First and Second Years of Life: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data.   Vaccine. 2007 Mar 12; [Epub ahead of print].

  37. Kmiecik, T.; Sek, K.; Gorski, P.  [Safety of Influenza Vaccination in Asthmatics.].   Pneumonol Alergol Pol. 2006; 74(4):365-371.

  38. Kohl, K. S.; Gidudu, J.; Bonhoeffer, J.; Braun, M. M.; Buettcher, M.; Chen, R. T.; Drammeh, B.; Duclos, P.; Heijbel, H.; Heininger, U.; Hummelman, E.; Jefferson, T.; Keller-Stanislawski, B.; Loupi, E.; Marcy, S. M.  The Development of Standardized Case Definitions and Guidelines for Adverse Events Following Immunization.   Vaccine. 2007 March 12; [Epub ahead of print]. VAERS

  39. Kunze, U.; Groman, E.; Bohm, G.; Kunze, M.   Influenza Vaccination in Austria, 1982-2003.  Wien Med Wochenschr.2007 Mar; 157(5-6):98-101.

  40. Launay, O.; Lortholary, O.  [Preventive Vaccination and Innovative Approaches.].   Med Sci (Paris). 2007 Apr; 23(4):339-341.

  41. Leung, A. Y.; Chow, H. C.; Kwok, J. S.; Lui, C. K.; Cheng, V. C.; Yuen, K. Y.; Lie, A. K.; Liang, R.  Safety of Vaccinating Sibling Donors With Live-Attenuated Varicella Zoster Vaccine Before Hematopoietic Stem Cell Transplantation.  Bone Marrow Transplant. 2007 Jun; 39(11):661-5. Epub 2007 Apr 9.

  42. Levine, O. S.; Cutts, F. T.  Pneumococcal Vaccination and Public Health.  Lancet. 2007 Apr 7; 369 (9568):1144-5.

  43. Liao, S. L.; Huang, T.; Huang, Y. C.; Jiang, D. D.  Survey of the Status of Self-Paid Varicella Vaccination Among Children One to Six Years of Age in Taiwan.   J Microbiol Immunol Infect. 2007 Apr; 40(2):112-5.

  44. Loughlin, S. M.; Mortazavi, A.; Garey, K. W.; Rice, G. K.; Birtcher, K. K.  Pharmacist-Managed Vaccination Program Increased Influenza Vaccination Rates in Cardiovascular Patients Enrolled in a Secondary Prevention Lipid Clinic.   Pharmacotherapy. 2007 May; 27(5):729-33.

  45. Luman, E. T.; Worku, A.; Berhane, Y.; Martin, R.; Cairns, L.  Comparison of Two Survey Methodologies to Assess Vaccination Coverage.   Int J Epidemiol. 2007 Apr 9; [Epub ahead of print].

  46. Makwana, N.; Riordan, F. A.  Bacterial Meningitis : The Impact of Vaccination.   CNS Drugs. 2007; 21(5):355-366.

  47. McPartlan, D.  Stop Pertussis Too.  Nursing2007 Apr;37(4):10.

  48. Melinkovich, P.; Hammer, A.; Staudenmaier, A.; Berg, M.  Improving Pediatric Immunization Rates in a Safety-Net Delivery System.   Jt Comm J Qual Patient Saf. 2007 Apr; 33 (4) 205-10.

  49. Millar, E. V.; O'Brien, K. L.; Bronsdon, M. A.; Madore, D.; Hackell, J. G.; Reid, R.; Santosham, M.  Anticapsular Serum Antibody Concentration and Protection Against Pneumococcal Colonization Among Children Vaccinated With 7-Valent Pneumococcal Conjugate Vaccine.  Clin Infect Dis. 2007 May1; 44 (9):1173-9. Epub 2007 Mar 23.

  50. Miller, E. R.; Iskander, J.; Pickering, S.; Varricchio, F.  How Can You Promote Vaccine Safety?  Nursing. 2007 Apr; 37(4):58-63; quiz 63-4. VAERS

  51. Modrzejewska, M.; Karczewicz, D.; Kordek, A.; Rudnicki, J.; Czajka, R.  [The Detachment of Retina As Possible Complication After BCG Vaccination During HOP--Description of Case].  Klin Oczna. 2006; 108(10-12):446-9.

  52. Mutz, I.; Spork, D.  [History of Recommendations for Immunizations in Austria.].   Wien Med Wochenschr. 2007 Mar; 157(5-6):94-7.

  53. Nates, S. V.; Martinez, L. C.; Barril, P. A.; Ferreyra, L. J.; Giordano, M. O.; Masachessi, G.; Isa, M. B.  Long-Lasting Poliovirus-Neutralizing Antibodies Among Argentinean Population Immunized With Four or Five Oral Polio Vaccine Doses 1 Month to 19 Years Previously. Viral Immunol. 2007 Spring; 20 (1):3-10.

  54. Niederhauser, V.; Walters, M.; Ganeko, R.  Simple Solutions to Complex Issues: Minimizing Disparities in Childhood Immunization Rates by Providing Walk-in Shot Clinic Access.  Fam Community Health2007 Apr-Jun; 30 (2 Suppl):S80-91.

  55. Orbach, H.; Shoenfeld, Y.  Vaccination Infection and Autoimmunity: Myth and Reality VIAMR 2005-10-26-28, Beau-Rivage Palace Hotel, Lausanne, Switzerland.   Autoimmun Rev; 6 (5): 261-266; April, 2007.

  56. Oymar, K.  [Allergy Vaccination in Norway].  Tidsskr Nor Laegeforen. 2007 Apr19; 127 (8):1036-8.

  57. Payne, D. C.; Rose, C. E., Jr.; Aranas, A.; Zhang, Y.; Tolentino, H.; Weston, E.; McNeil, M. M.; Ruscio, B.  Assessment of Anthrax Vaccination Data in the Defense Medical Surveillance System, 1998-2004.   Pharmacoepidemiol Drug Saf. 2007 Apr 16; [Epub ahead of print].

  58. Peters, T. R.; Poehling, K. A.  Invasive Pneumococcal Disease: the Target Is Moving.   JAMA. 2007 Apr 15; 297(16):1825-.

  59. Pham, T. B.; Nguyen, T. H.; Vu, T. Q.; Nguyen, T. L.; Malvy, D.  [Predictive Factors of Dengue Shock Syndrome at the Children Hospital No. 1, Ho-Chi-Minh City, Vietnam].   Bull Soc Pathol Exot. 2007 Feb; 100 (1):43-7.

  60. Poehling, K. A.; Szilagyi, P. G.; Grijalva, C. G.; Martin, S. W.; LaFleur, B.; Mitchel, E.; Barth, R. D.; Nuorti, J. P.; Griffin, M. R.  Reduction of Frequent Otitis Media and Pressure-Equalizing Tube Insertions in Children After Introduction of Pneumococcal Conjugate Vaccine.  Pediatrics. 2007 Apr; 119(4): 707-15.

  61. Pollard, A. J.  Childhood Immunisation: What Is the Future?  Arch Dis Child. 2007 May; 92(5):426-33.

  62. Pontrelli, G.; Albore, M.; Franco, E.  [Strategies of Immunization in Ghana: the Experience of a "Community-Based" Health Planning in a Rural Country].  Ig Sanita Pubbl. 2007 Jan-Feb; 63(1):95-100.

  63. Reid, J. K.; Ward, H.; Marciniuk, D.; Hudson, S.; Smith, P.; Hoeppner, V.  The Effect of Neonatal BCG Vaccination on PPD Testing on Canadian Aboriginal Children.  Chest. Mar 30; [Epub ahead of print].

  64. Renner, L. A.; Newman, M. J.; Ahadzie, L.; ntwi-Agyei, K. O.; Eshetu, M.  Introduction of Haemophilus Influenzae Type B Conjugate Vaccine into Routine Immunization in Ghana and Its Impact on Bacterial Meningitis in Children Younger Than Five Years.   Pediatr Infect Dis J. 2007 Apr; 26(4):356-8.

  65. Ruggeberg, J. U.; Gold, M. S.; Bayas, J. M.; Blum, M. D.; Bonhoeffer, J.; Friedlander, S.; de Souza, Brito G.; Heininger, U.; Imoukhuede, B.; Khamesipour, A.; Erlewyn-Lajeunesse, M.; Martin, S.; Makela, M.; Nell, P.; Pool, V.; Simpson, N.  Anaphylaxis: Case Definition and Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data. Vaccine. 2007 Mar 12; [Epub ahead of print].

  66. Sandberg, K. I.; Bjune, G.  The Politics of Global Immunization Initiatives: Can We Learn From Research on Global Environmental Issues?  Health Policy.2007 Apr 19; [Epub ahead of print]

  67. Scheiblhofer, S.; Weiss, R.; Thalhamer, J.   [Genetic Immunization: New Ways for Protective and Therapeutic Vaccines Against Allergic Diseases.].   Wien Med Wochenschr. 2007 Mar; 157 (5-6):111-5.

  68. Schmitt, B.; Dobrez, D.; Parada, J. P.; Kyriacou, D. N.; Golub, R. M.; Sharma, R.; Bennett, C.  Responding to a Small-Scale Bioterrorist Anthrax Attack: Cost-Effectiveness Analysis Comparing Preattack Vaccination With Postattack Antibiotic Treatment and Vaccination.  Arch Intern Med. 2007 Apr; 167(7): 655-62.

  69. Shah, A.  BCG Vaccination and Tuberculous Meningitis.  Indian Pediatr. 2007 Mar; 44 (3):221; March, 2007.

  70. Shah, R.  BCG Vaccination and Tuberculous Meningitis-Reply.  Indian Pediatr. 2007 Mar; 44(3):221-2.

  71. Shoaib, A.; Rethnam, U.; Bansal, R.; Clay, N.  The Effects of Mass Immunization on Haemophilus Influenzae Type B-Related Orthopaedic Disease.  J Pediatr Orthop B. 2007 May; 16(3):236-238.

  72. Singleton, R. J.; Hennessy, T. W.; Bulkow, L. R.; Hammitt, L. L.; Zulz, T.; Hurlburt, D. A.; Butler, J. C.; Rudolph, K.; Parkinson, A.  Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage.  JAMA. 2007 Apr 25; 297(16):1784-92.

  73. Tabira, T.; Hara, H.  [Vaccination--Update].   Rinsho Shinkeigaku. 2006 Nov; 46(11):927.

  74. Tay, L.; Leon, F.; Vratsanos, G.; Raymond, R.; Corbo, M.  Vaccination Response to Tetanus Toxoid and 23-Valent Pneumococcal Vaccines Following Administration of a Single Dose of Abatacept: a Randomized, Open-Label, Parallel Group Study in Healthy Subjects.  Arthritis Res Ther. 2007 Apr 10; 9(2):R38 [Epub ahead of print]

  75. Thyr, M.; Sundholm, A.; Teeland, L.; Rahm, V. A.  Oral Glucose As an Analgesic to Reduce Infant Distress Following Immunization at the Age of 3, 5 and 12 Months.   Acta Paediatr. 2007 Feb;96(2):233-6.

  76. Turner, C. J.; Ellis, S.; Giles, J.; Altiere, R.; Sintek, C.; Ulrich, H.; Valdez, C.; Zadvorny, E.  An Introductory Pharmacy Practice Experience Emphasizing Student-Administered Vaccinations.   Am J Pharm Educ. 2007 Feb 15; 71(1): 3.

  77. Twine, C.; Coulston, J.; Tayton, K.  Bony Lesions in BCG-Vaccinated Children: Consider BCG Osteitis.   J Paediatr Child Health. 2007 Apr; 43(4):307-9.

  78. Wang, Y. Y.; Wang, Y.; Zhang, J. X.; Kang, C. Y.; Duan, P.  [Status of Mother's KAP on Child Immunization in Minority Areas, Guizhou Province].   Beijing Da Xue Xue Bao. 2007 Apr 18; 39(2):136-9.

  79. Widdowson, M. A.; Meltzer, M. I.; Zhang, X.; Bresee, J. S.; Parashar, U. D.; Glass, R. I.  Cost-Effectiveness and Potential Impact of Rotavirus Vaccination in the United States.  Pediatrics. 2007 Apr; 119(4):684-97.

  80. Woodhall, S. C.; Lehtinen, M.; Verho, T.; Huhtala, H.; Hokkanen, M.; Kosunen, E.  Anticipated Acceptance of HPV Vaccination at the Baseline of Implementation: a Survey of Parental and Adolescent Knowledge and Attitudes in Finland.   J Adolesc Health. 2007 May; 40(5):466-9.